<DOC>
	<DOCNO>NCT00985010</DOCNO>
	<brief_summary>Objective : Report manganese serum level mortality encephalopathic patient . Patients participant : Consecutive patient age &gt; 18 year , hepatic encephalopathy inform consent sign family . Interventions : Patients ' clinical characteristic well biochemical test renal function , hemoglobin , glucose albumin level obtain well blood sample analyze manganese level graphite furnace atomic absorption spectrometer . Hypothesis : There difference manganese level male female patient .</brief_summary>
	<brief_title>Manganese Women With Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Manganese</mesh_term>
	<criteria>Consecutive patient age &gt; 18 year With hepatic encephalopathy Informed consent sign family Portal bypass surgery Cancer localization Known malignancy severe disease shorten life expectancy &lt; 6 month Psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>hepatic encephalopathy</keyword>
	<keyword>hepatitis C</keyword>
	<keyword>manganese</keyword>
	<keyword>mortality</keyword>
	<keyword>prognosis .</keyword>
</DOC>